EMIS Pinnacle, the leading Pharmacy First IT supplier, has begun implementing the GP Connect Update Record feature to all community pharmacies in England that
use PharmOutcomes.
Starting June 28, this new feature was made available for use with the Hypertension case-finding service and the Pharmacy contraception service, as announced by
the Community Pharmacy England (CPE).
The GP Connect Update Record will enable community pharmacies to securely share "structured" information with GP practices regarding consultations conducted under
the Pharmacy First programme, which includes minor illness and clinical pathways, along with Hypertension Case Finding and Pharmacy Contraception services
Live testing is underway with EMIS Pinnacle for Pharmacy First minor illness and clinical pathways.
There are plans to expand the system in the future to include updates for urgent supply of medicines under the Pharmacy First service.
EMIS Pinnacle is the third CPCF IT system supplier to offer this functionality, following Cegedim's Pharmacy Services system and Positive Solutions' HXConsult
system.
Community Pharmacy England (CPE) is organising a series of webinars to help pharmacy owners and their teams to prepare for the implementation of new
Pharmacy First service, and changes to the Contraception and Hypertension Case-Finding Services.
Beginning from 5th December, the webinars would be conducted throughout December and January, with support from NHS England and the Centre for Postgraduate
Education (CPPE), the organisation announced on Thursday (30 November).
During the online seminars, pharmacy teams will be explained about the individual services announced, and things to consider before they start providing, or
expand their offering of, these services.
Each webinar will have CPE's Services Team, who would be leading the team, and policy experts from NHS England and CPPE as speakers.
Community Pharmacy England (CPE) is aiming to reach an agreement with the Department of Health and Social Care (DHSC) and NHS England (NHSE) on negotiation
with regards to expanded services and payment model in the pharmacy sector.
Chief Executive Janet Morrison, said: "We are working at pace in negotiations with DHSC and NHSE. The process remains on track with the Government's original
timescale - i.e. aiming for agreement in July, with cross-government clearance later in July, and implementation from July through to September."
CPE is involved in working groups on service expansion of Hypertension Case-Finding and the Pharmacy Contraception Scheme and service design for the Common
Conditions Service; and are in in-depth negotiations on Payment models.
These discussions critically look at the balance between funding core capacity and activity payments, how the funding streams will be distributed and how CPE
will measure delivery and impact.
NHSE has been leading on the development of the PGD pathways for each of the 7 conditions, with external medical, pharmacy and other experts feeding into the
process - pharmacy owners from the Community Pharmacy England Committee have also been involved but the discussions are clinically led to ensure they comply with
NICE principles and concur with Antimicrobial Stewardship policy.
Boots UK has agreed to grant a five per cent pay increase to its pharmacists following a collaborative agreement with the Pharmacists' Defence
Association (PDA). This raise acknowledges the unique market conditions faced by pharmacists in the community pharmacy sector, Boots UK and PDA said in a
joint statement on Oct. 9.
According to the statement, the pay increase applies to all pharmacists within the PDA Union's bargaining unit, except for those who joined or received a pay
raise after August 2023. Moreover, trainee pharmacists or those not meeting performance standards are not eligible for the raise.
Additionally, pharmacists and store managers will receive a pro-rata, one-time non-consolidated payment of £750 in August 2024. This payment serves as recognition
for their dedication to establishing and providing new core and advanced NHS services, particularly in light of the substantial changes anticipated in the upcoming
year, the joint statement said.
The services include new medicines, hypertension, contraception, and common conditions services in England, the clinical community pharmacy service in Wales, and
the Pharmacy First services in Scotland and Northern Ireland.